UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells

Dr. Paul Offit, an international expert on vaccines, will give the 2020 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside

UC Riverside mouse study focused on neurons in the hippocampus

Osmotic therapy device reduces swelling to prevent secondary injuries in rats

UC Riverside-led study identifies mechanism that prevents death of neurons

Adam Godzik has been named the Bruce D. and Nancy B. Varner Presidential Endowed Chair in Cancer Research

Total funding of three grants exceeds $1.2 million

UC Riverside mouse study will identify mechanisms the gene PTPN2 uses to affect gut cells

UC Riverside-led study shows inhibiting two host cell proteases can accomplish the task

Research supported by five-year NIH grant may have relevance for COVID-19 patients

UC Riverside biomedical scientist Marcus Kaul explains

Drugs previously in development for SARS could be effective for COVID-19

NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors

UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut

UC Riverside-led study tested the effects of microgravity on intestinal epithelial cells

UC Riverside mouse study finds early exposure to sounds can address hypersensitivity to noise associated with Fragile X Syndrome

The shape and architecture of collagen and elastin fibers can improve our understanding of lung diseases, including the one associated with vaping

UC Riverside-led research could aid regenerative stem cell therapies

Research is supported by a five-year grant to UC Riverside from the National Institutes of Health

UC Riverside-led mouse study focuses on cannabis-like molecules that augment feeding behavior